Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 68.750
Filtrar
1.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde, LIS-bvsms | ID: lis-LISBR1.1-46835

RESUMO

A efetividade das vacinas contendo o componente sarampo é influenciada pela idade à vacinação, de tal forma que crianças vacinadas em idade menor do que 12 meses apresenta efetividade de 84% e aos 12 meses 92,5%


Assuntos
Vacinação , Programas de Imunização
2.
Cent Eur J Public Health ; 27(3): 204-211, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31580555

RESUMO

OBJECTIVES: Vaccine preventable diseases (VPDs) continue to pose a significant threat to healthcare workers (HCWs) while immunization among this group remains low. HCWs' behaviours as well as facilitators and barriers towards their vaccination for a number of VPDs were explored through an EU-wide survey. METHODS: HCWs across the EU answered online survey that explored attitudes and behaviours towards vaccination for a number of VPDs. Response data were adjusted based on weights estimated by HCWs' country and working profession according to WHO statistics. The survey was delivered between October 2012 and April 2014. RESULTS: Analysis was based on responses from 5,424 HCWs from 14 European countries. The majority (86.7%) had a positive attitude regarding immunizations. HCWs considered influenza (86.4%), viral hepatitis type B (71.9%) and tuberculosis (59.1%) as higher risk diseases for occupational exposure in the workplace. However, 43.8% reported not receiving a seasonal influenza vaccine in the last 10 years and 65.6% reported not receiving the pandemic influenza vaccine in 2009. Main enablers towards immunizations included believing in vaccine protection and easy, free of charge access to vaccines in the workplace. Barriers to up-to-date immunizations differed according to disease but included concerns about short- and long-term effects. CONCLUSION: Although the concept of mandatory vaccination seems to be favoured by many health professionals in Europe, it remains a controversial subject both among HCWs' profession categories and also among different countries. Interventions to increase vaccination among HCWs would benefit by tailoring their approach according to disease and target group.


Assuntos
Imunização , Vacinas contra Influenza , Europa (Continente) , Pessoal de Saúde , Humanos , Inquéritos e Questionários , Vacinação
3.
J Assoc Physicians India ; 67(10): 80-82, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31571462

RESUMO

Dengue is the most common arboviral disease affecting many countries worldwide. With endemicity of the disease and huge burden, atypical clinical presentations occur posing high diagnostic and therapeutic dilemma. Emerging neurological complications in dengue fever are reported in recent past Acute disseminated encephalomyelitis (ADEM) is an immune mediated acute demyelinating disorder of the central nervous system following recent infection or vaccination and characterized by multifocal white matter involvement. Early suspicion and diagnosis of such complication is clinical dilemma and it further complicates the clinical scenario. This case report highlights occurrence of such uncommon manifestation of ADEM in commonly occurring dengue fever along with its diagnosis and successful management in a young individual.


Assuntos
Dengue , Encefalomielite Aguda Disseminada , Humanos , Imagem por Ressonância Magnética , Doenças do Sistema Nervoso , Vacinação
4.
Rev Med Suisse ; 15(660): 1521-1525, 2019 Aug 28.
Artigo em Francês | MEDLINE | ID: mdl-31496178

RESUMO

The Swiss 2019 immunization schedule published includes 7 news clauses: 1) DTPa-IPV-Hib-HBV vaccination in newborns with the simplified dosing schedule "2+1"; 2) recommendation for vaccination against measles, mumps and rubella administered at 9 and 12 months of age; 3) pneumococcal immunization in children under 5 years of age as a basic recommendation; 4) replacement of the monovalent capsular group C meningococcal conjugate vaccine by the quadrivalent ACWY conjugate vaccine (Menveo); 5) extension of vaccination against tick-borne encephalitis virus to the entire Swiss territory - with the exception of the cantons of Geneva and Tessin - in people with risk factors for contagion; 6) replacement of Gardasil® with Gardasil 9® since January 2019; 7) recommendation for vaccination against hepatitis B in newborns.


Assuntos
Esquemas de Imunização , Vacinas/administração & dosagem , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Vacinação/normas
5.
Pan Afr Med J ; 33: 96, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31489074

RESUMO

Introduction: Hepatitis B vaccination among healthcare workers (HCWs) in Ghana has not been actively pursued despite the endemicity of the infection. This study measures the hepatitis B vaccine uptake among HCWs at the University of Ghana Hospital, Legon (UGHL) and identifies the factors associated with vaccination. Methods: An analytical cross-sectional study involving all staff who have direct contact with patients was conducted. Self-administered questionnaires were used to collect data on vaccination status, age, sex, type of staff, duration of work in the facility, exposure to blood or blood products, blood stained linens/waste, sharp instruments and performance of invasive procedures. Data was analysed using STATA 14. Continuous variables were described using median values and interquartile ranges (IQR) and categorical variables as proportions. Bivariate and multivariate analysis were conducted to identify the factors associated with hepatitis B vaccination status. Results: Of the 161 participants interviewed, 63.4% were females with median age 35 years (IQR: 27-45). Eighty-six (53.4%) of the respondents had taken the hepatitis B vaccine with 79.1% of them having completed the vaccination schedule. Factors associated with vaccination were working for more than 16 years (OR: 3.8, CI: 1.02-12.72), daily exposure to blood/blood products (OR: 4.1, CI: 1.43-11.81) and sharp instruments (OR: 4.45, CI: 1.39- 14.24), performing invasive procedures daily (OR: 3.0, CI: 1.07-8.45) and frequent exposure to blood stained linens/waste (OR: 6.1, CI: 1.41-26.51). Conclusion: The lack of hepatitis B vaccination among some HCWs at UGHL puts them at risk of contracting hepatitis B infection.


Assuntos
Vacinas contra Hepatite B/administração & dosagem , Hepatite B/prevenção & controle , Recursos Humanos em Hospital/estatística & dados numéricos , Vacinação/estatística & dados numéricos , Adulto , Estudos Transversais , Feminino , Gana , Hepatite B/transmissão , Humanos , Esquemas de Imunização , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Doenças Profissionais/prevenção & controle , Doenças Profissionais/virologia , Exposição Ocupacional/estatística & dados numéricos , Inquéritos e Questionários , Fatores de Tempo , Adulto Jovem
6.
Artigo em Chinês | MEDLINE | ID: mdl-31495113

RESUMO

Objective: To understand the current situation of blood-borne occupational exposure among health care workers and evaluate the intervention effect of PDCA. Methods: Retrospective survey was adopted to investigate and analyze the blood-borne occupational exposure incidents in a hospital from January 2015 to December 2018, and to compare the intervention effects after PDCA management. Results: A total of 82 cases of occupational exposure occurred from 2015 to 2017, and only 9 cases happened after the implementation of PDCA intervention. The exposed population was mainly consisted of nurses (59 cases, 64.83%) , and mainly with low-working age (1-5 years) (56 cases, 61.54%) , and the main source of exposure was hepatitis B (34 cases, 37.36%) . In addition, after the implementation of PDCA, the vaccination rate of personnel was 77.78%, the standardized field treatment rate was 100%, the preventive drug use rate was 88.89%; The qualified rate of occupational protection assessment was higher than that before intervention, which all shows the difference was statistically significant (P<0.05) . Conclusion: With the guide of PDCA management, Strengthen the training of new employees or ones with low working years as well as their awareness of protection, and standardize the relevant operational procedures, which can significantly improve the prevention of blood-borne occupational exposure and stress management of medical staff.


Assuntos
Patógenos Transmitidos pelo Sangue , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Corpo Clínico , Exposição Ocupacional/prevenção & controle , Pessoal de Saúde , Hepatite B/epidemiologia , Humanos , Enfermeiras e Enfermeiros , Doenças Profissionais , Estudos Retrospectivos , Vacinação/estatística & dados numéricos
7.
Artigo em Inglês | MEDLINE | ID: mdl-31522661

RESUMO

The Influenza Complications Alert Network (FluCAN) is a sentinel-hospital-based surveillance program that operates at sites in all jurisdictions in Australia. This report summarises the epidemiology of hospitalisations with laboratory-confirmed influenza during the 2017 influenza season. In this observational surveillance system, cases were defined as patients admitted to any of the 17 sentinel hospitals with influenza confirmed by nucleic acid detection. Data are also collected on a frequency-matched control group of influenza-negative patients admitted with acute respiratory infection. During the period 3 April to 31 October 2017 (the 2017 influenza season), 4,359 patients were admitted with confirmed influenza to one of 17 FluCAN sentinel hospitals. Of these, 52% were elderly (≥65 years), 14% were children (<16 years), 6.5% were Aboriginal and Torres Strait Islander peoples, 1.6% were pregnant and 78% had chronic comorbidities. A significant proportion were due to influenza B (31%). Estimated vaccine coverage was 72% in the elderly (≥65 years), 50% in non-elderly adults with medical comorbidities and 24% in children (<16 years) with medical comorbidities. The estimated vaccine effectiveness (VE) in the target population was 23% (95% CI: 7%, 36%). There were a large number of hospital admissions detected with confirmed influenza in this national observational surveillance system in 2017, with case numbers more than twice that reported in 2016.


Assuntos
Vírus da Influenza B/imunologia , Vacinas contra Influenza/imunologia , Influenza Humana/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Austrália/epidemiologia , Estudos de Casos e Controles , Comorbidade , Feminino , Hospitalização , Hospitais , Humanos , Vírus da Influenza B/classificação , Vírus da Influenza B/genética , Influenza Humana/etnologia , Influenza Humana/virologia , Masculino , Pessoa de Meia-Idade , Grupo com Ancestrais Oceânicos , Gravidez , Vigilância de Evento Sentinela , Vacinação , Adulto Jovem
8.
Acta Virol ; 63(3): 245-252, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31507189

RESUMO

Plants have been as medicinal mediators for centuries. Recent trends in agro-biotechnology however, improved the therapeutic roles of plants to a significant level and introduced plant-based oral vaccine which can arouse an immune response in consumer. Although conventional vaccines against infectious diseases have been administrated for years the discovery of plant-based oral vaccines can potentially replace them completely in the future. The probable limitations in conventional vaccines are found to be overcome by plant-based oral vaccines. Humans and animals will no longer be dependent upon local or systemic administration of vaccines but they will just receive the vaccines as a routine food. For the purpose, gene of interest is introduced into plant through transformation, and expression of specific antigen is obtained in plant products which are then consumed by humans or animals. Therefore, plants can serve as bioreactors or bio-factories for production of edible vaccines. A detailed overview about edible vaccines, methods for edible vaccine production, candidate bioreactors and future perspectives of edible vaccines has been summarized in current article. The future of vaccination seems to be present within plant-based vaccination system. Keywords: vaccine; edible vaccine; infectious diseases; antigen; edible crops; oral immunization.


Assuntos
Controle de Doenças Transmissíveis , Vacinação , Vacinas , Administração Oral , Animais , Humanos , Plantas Geneticamente Modificadas , Vacinação/métodos , Vacinas/administração & dosagem , Vacinas de Plantas Comestíveis
10.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde, LIS-bvsms | ID: lis-LISBR1.1-46762

RESUMO

Calendário de vacinação do SUS para cidadãos de todas as idades.


Assuntos
Programas de Imunização , Sistema Único de Saúde , Vacinação
11.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde, LIS-bvsms | ID: lis-LISBR1.1-46763

RESUMO

A imunização correta pode evitar essas doenças. A primeira dose da tríplice viral deve ser ministrada aos 12 meses de idade. Aos 15 meses, uma dose da vacina tetraviral (sarampo, caxumba, rubéola e varíola), que corresponde à segunda dose da vacina tríplice e uma dose da varicela.


Assuntos
Vacina contra Sarampo-Caxumba-Rubéola , Vacinação , Programas de Imunização , Sistema Único de Saúde
12.
Recurso na Internet em Português | LIS - Localizador de Informação em Saúde | ID: lis-LISBR1.1-46748

RESUMO

A Região das Américas confirmou 2.927 casos de sarampo neste ano. Os dados são da mais recente atualização epidemiológica da Organização Pan-Americana da Saúde (OPAS), com dados fechados no último dia 7 de agosto. A doença foi identificada em 14 países, de 1 janeiro a 27 de julho, sendo a maior proporção registrada nos Estados Unidos (1.172), Brasil (1.045) e Venezuela (417).


Assuntos
Sarampo , Vacinação
13.
Stud Health Technol Inform ; 264: 1855-1856, 2019 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-31438377

RESUMO

Vaccination against influenza is important in pregnancy for the health of both mother and unborn baby. Influenza introduces risks to pregnancy and to the baby who relies on maternal antibodies for protection. Because the data associated with pregnancy is fragmented across multiple providers of health care, it is challenging to conduct pregnancy-related public health surveillance using a single data source. We report the integration of a novel ontological approach to identifying pregnancies in routine data with a web-based dashboard that feeds back information to general practices in a sentinel network. As a result, practices receive information about how well they are performing influenza vaccination in pregnancy in near-real-time.


Assuntos
Armazenamento e Recuperação da Informação , Feminino , Humanos , Vacinas contra Influenza , Influenza Humana , Gravidez , Complicações Infecciosas na Gravidez , Gestantes , Atenção Primária à Saúde , Vacinação
14.
MMWR Morb Mortal Wkly Rep ; 68(32): 698-702, 2019 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-31415491

RESUMO

Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including some cancers. The Advisory Committee on Immunization Practices (ACIP)* routinely recommends HPV vaccination at age 11 or 12 years; vaccination can be given starting at age 9 years. Catch-up vaccination has been recommended since 2006 for females through age 26 years, and since 2011 for males through age 21 years and certain special populations through age 26 years. This report updates ACIP catch-up HPV vaccination recommendations and guidance published in 2014, 2015, and 2016 (1-3). Routine recommendations for vaccination of adolescents have not changed. In June 2019, ACIP recommended catch-up HPV vaccination for all persons through age 26 years. ACIP did not recommend catch-up vaccination for all adults aged 27 through 45 years, but recognized that some persons who are not adequately vaccinated might be at risk for new HPV infection and might benefit from vaccination in this age range; therefore, ACIP recommended shared clinical decision-making regarding potential HPV vaccination for these persons.


Assuntos
Vacinas contra Papillomavirus/administração & dosagem , Vacinação/normas , Adulto , Comitês Consultivos , Centers for Disease Control and Prevention (U.S.) , Feminino , Humanos , Esquemas de Imunização , Masculino , Infecções por Papillomavirus/prevenção & controle , Estados Unidos
15.
Vet Immunol Immunopathol ; 214: 109890, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31378218

RESUMO

Bovine mastitis is a significant cause of economic losses in the dairy industry. Staphylococcus aureus is one of the most common contagious mastitis pathogens, whereas Staphylococcus chromogenes increasingly became a significant cause of subclinical mastitis in dairy cows. Current mastitis control measures are not effective on all mastitis pathogens. There is no effective vaccine to control Staphylococcal mastitis in dairy cows. The objective of this study was to evaluate the immune responses and protection in dairy cows vaccinated with S. aureus surface proteins (SASP) or S. chromogenes surface proteins (SCSP). We divided eighteen Holstein dairy cows randomly into three groups of 6 animals each. We vaccinated group 1 and 2 animals with SASP and SCSP with Emulsigen-D adjuvant, respectively. We injected control (group 3) animals with PBS (pH 7.2) in Emulsigen®-D. We vaccinated animals three times at 28 and 14 days before drying off, and at dry off. Two weeks after the third vaccination, we challenged each animal by dipping all teats in S. aureus culture suspension once daily for 14 consecutive days. We evaluated milk or mammary secretion and serum antibody titers during vaccination and challenge periods. We evaluated milk samples for the number of bacteria shedding and somatic cell counts (SCC). Out of six cows vaccinated with SASP, one cow was removed from the study due to injury, two were infected clinically, another two were infected subclinically, and the remaining cow was not infected. No SCSP vaccinated cows developed clinical or subclinical mastitis. Out of six control cows, two developed clinical mastitis whereas four were infected subclinically. The SCSP vaccine cross-protected against S. aureus mastitis and reduced number of S. aureus shedding in milk. We concluded that the SCSP is a promising vaccine to control Staphylococcal mastitis in dairy cows.


Assuntos
Mastite Bovina/prevenção & controle , Proteínas de Membrana/imunologia , Infecções Estafilocócicas/veterinária , Vacinas Antiestafilocócicas/imunologia , Staphylococcus aureus/imunologia , Animais , Derrame de Bactérias , Bovinos , Contagem de Células , Indústria de Laticínios , Feminino , Proteínas de Membrana/administração & dosagem , Leite/microbiologia , Infecções Estafilocócicas/imunologia , Infecções Estafilocócicas/prevenção & controle , Vacinação
16.
Wiad Lek ; 72(7): 1274-1280, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31398155

RESUMO

OBJECTIVE: Introduction: Several studies has shown that rotaviruses play a leading role in the structure of acute intestinal infections (AII) of viral etiology in children. In the National vaccination calendar of Ukraine, vaccination against rotavirus infection (RVI) is classified as recommended, with the expected goal of reducing the number of severe RVI cases among under five-year-old children. Nevertheless, despite the positive epidemiological and clinical effects of vaccination against RVI, it remains unclear how appropriate the introduction of rotavirus vaccines is in terms of potential costs and benefits, as well as determining the optimal level of subsidy required to cover part of the costs of voluntary vaccination of the population. The aim: Study of optimal subsidy level of rotavirus vaccine in Ukraine using epidemiological and pharmacoeconomic modeling. PATIENTS AND METHODS: Materials and methods: The retrospective epidemiological data of the monthly RVI incidence in Ukraine as well as the population number from 2010 to 2016 formed the information basis for determining the transmission parameter of the viral agent. The scenario of RVI epidemic process as an acute intestinal infection from the point of view of mathematical epidemiology is best described by developed mathematical model. Cost-benefit of rotavirus vaccination was studied with the use of developed pharmacoeconomic criteria. RESULTS: Results and conclusions: Prediction of possible implications of RVI vaccination and finding optimal level of vaccine supply involves a comprehensive study of the epidemic process peculiarities of this infection with development of an adequate epidemiological model. We have proposed a model of RVI epidemiological process in Ukraine, determining its main parameters with the use of available retrospective data of anual number of RVI cases for the period from 2010 to 2016. The developed model was used as an analytical tool for analyzing influence of different levels of vaccine supply on vaccination cost-benefit. The results of research showed that the use of epidemiological modeling in pharmacoeconomic analysis of rotavirus vaccination made it possible to determine analytically optimal level of vaccination subsidy level.


Assuntos
Gastroenterite , Vacinas contra Rotavirus , Farmacoeconomia , Humanos , Estudos Retrospectivos , Ucrânia , Vacinação , Vacinas Atenuadas
17.
Sr Care Pharm ; 34(7): 432-438, 2019 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-31383053

RESUMO

OBJECTIVE: To describe an interdisciplinary academic detailing project implemented to address low pneumococcal immunization rates. SETTING: Two medical clinics and four community pharmacies in rural Washington state. PRACTICE DESCRIPTION: The two medical clinics and four community pharmacies were all located in two rural counties and serve geographically large rural areas. PRACTICE INNOVATION: Academic detailing is an evidence-based approach designed to change clinical practice and improve decision-making. Our team utilized the academic detailing model to provide educational outreach to local rural health care providers. The detailing team visited each clinic and pharmacy on a defined schedule and provided information to physicians, clinic administrators, nurses, pharmacists, pharmacy technicians, medical assistants, and clinic front-end staff. MAIN OUTCOME MEASUREMENTS: The project team maintained detailed field notes from each academic detailing the visit and met to debrief about each encounter. From the field notes, through the process of thematic analysis and analytic memoing, the project team produced a list of "lessons learned" that could be used to guide other interprofessional teams wishing to embark on an academic detailing project. RESULTS: We have identified four key "lessons learned": Interprofessional team members bring different strengths to the project; using same-discipline team members paved the way for success; involving students aids in educating future practitioners in interprofessional practice; and scheduling meetings in advance is important. CONCLUSION: We described an approach to enhanced academic detailing using interprofessional team delivery, bringing interprofessional practice into the real-world practice setting.


Assuntos
Infecções Pneumocócicas/prevenção & controle , Vacinação , Idoso , Assistência à Saúde , Humanos , Washington
18.
Exp Parasitol ; 205: 107733, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31408623

RESUMO

Toxoplasma gondii is a ubiquitous protozoan of major medical and veterinary importance. Its treatment is difficult since the available drugs have severe side effects and reactivation may occur anytime. Vaccination with irradiated parasites exhibits ideal characteristics for vaccine development. In our experimental mice model, the protection against challenge with the virulent RH strain was assessed, using 255Gy irradiated tachyzoites. Eighty mice were allocated into 3 groups: naive control group, challenged with virulent RH tachyzoites group and a third group which is challenged with 1 × 106 irradiated tachyzoites, administered as two biweekly doses intraperitoneally. Protection was tested by challenging vaccinated mice with the virulent type RH tachyzoites 30 days after the 2nd vaccination dose. The assessment was built on qualitative clinical, quantitative parasitological, histopathological parameters and measurement of serum Nitric Oxide (NO). The results showed prolonged survival rate, absence of tachyzoites in the peritoneal aspirate by counting, absence of tachyzoites in all examined organs by impression smears, amelioration of histopathological changes in the liver, spleen, brain and lung specimens and increase of the serum NO level in the vaccinated group. Therefore, we propose that irradiated Toxoplasma tachyzoites confer protection for challenged mice and could be an alternative immunization schedule for vaccine development especially for who are at risk of severe immunosuppression.


Assuntos
Toxoplasma/imunologia , Toxoplasma/efeitos da radiação , Toxoplasmose Animal/prevenção & controle , Toxoplasmose Animal/parasitologia , Vacinação/métodos , Animais , Líquido Ascítico/parasitologia , Encéfalo/parasitologia , Encéfalo/patologia , Colorimetria , Feminino , Raios gama , Fígado/parasitologia , Fígado/patologia , Pulmão/parasitologia , Pulmão/patologia , Camundongos , Óxido Nítrico/análise , Baço/parasitologia , Baço/patologia , Taxa de Sobrevida , Toxoplasmose Animal/imunologia , Toxoplasmose Animal/mortalidade
19.
Pan Afr Med J ; 33(Suppl 2): 5, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31402965

RESUMO

Introduction: The Ebola virus disease (EVD) outbreak in Liberia from 2014-2015 setback the already fragile health system which was recovering from the effects of civil unrest. This led to significant decline in immunization coverage and key polio free certification indicators. The Liberia investment plan was developed to restore immunization service delivery and overall health system. Methods: We conducted a desk review to summarize performance of immunization coverage, polio eradication, measles control, new vaccines and technologies. Data sources include program reports, scientific and grey literature, District Health Information System (DHIS2), Integrated Diseases Surveillance and Response (IDSR) database, auto visual AFP detection and reporting (AVADAR) and ONA Servers. Data analysis was done using Microsoft excel spreadsheets, ONA software and Arc GIS. Results: There was a 36% increase in national coverage for Penta 3 in 2017 compared to 2014 from WUENIC data. Penta 3 dropout rate reduced by 2.5 fold from 15.3% in 2016 to 6.4% in 2017; while MCV1 coverage improved by 23% from 64% in 2015 to 87% in 2017. There was a rebound of non-polio AFP rate (NPAFP) rate from 1.2 in 2015 to 4.3 in 2017. Furthermore, there was a 2-fold increase in the number of AFP cases receiving 3 or more doses of OPV from 36% in 2015 to 61% in 2017. Conclusion: Liberia demonstrated strong rebound of immunization services following the largest and most devastating EVD outbreak in West Africa in 2014 - 2015. Immunization coverage improved and dropout rates reduced. However, there are still opportunities for improvement in the immunization program both at national and sub-national levels.


Assuntos
Surtos de Doenças/prevenção & controle , Programas de Imunização/organização & administração , Cobertura Vacinal , Vacinação/métodos , Doença pelo Vírus Ebola/epidemiologia , Humanos , Libéria/epidemiologia , Poliomielite/epidemiologia , Poliomielite/prevenção & controle , Vigilância em Saúde Pública/métodos , Vacinas/administração & dosagem
20.
Stud Health Technol Inform ; 264: 1003-1006, 2019 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-31438075

RESUMO

Influenza is an important public health problem with consequences on the health of people, but also at the state level with social and health costs due to the morbidity and mortality produced. Vaccination is an act of care of high clinical complexity, which can be learned and trained, so that decision-making in vaccination requires elements of judgment that act logically in a cascade. The creation of algorithms and their implementation in computer systems will identify susceptible people more quickly and improve the competence in the administration of vaccines. For the creation of the algorithm, the variables and their relationships were identified through mathematical formulation. As a result, the nine variables for vaccination that result in 47 different clinical situations were identified (29 "non-vaccination" and 18 "vaccination" situations). The formalization of algorithms in vaccine administration allows to represent the process by which the professional carries out the decision making process.


Assuntos
Vacinas contra Influenza , Influenza Humana , Algoritmos , Tomada de Decisões , Humanos , Vacinação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA